{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:10:28Z","timestamp":1791252628136,"version":"4.1.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00415-009-5243-y","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T01:56:45Z","timestamp":1251251805000},"page":"270-279","source":"Crossref","is-referenced-by-count":161,"title":["Formation and development of Lewy pathology: a critical update"],"prefix":"10.1007","volume":"256","author":[{"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,27]]},"reference":[{"key":"5243_CR1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000122963","volume":"25","author":"L Aho","year":"2008","unstructured":"Aho L, Parkkinen L, Pirttila T, Alafuzoff I (2008) Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects. Dement Geriatr Cogn Disord 25:423\u2013432","journal-title":"Dement Geriatr Cogn Disord"},{"key":"5243_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/nen.0b013e3181633526","volume":"67","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Parkkinen L, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Morris J, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H (2008) Assessment of \u03b1-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 67:125\u2013143","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR3","doi-asserted-by":"crossref","unstructured":"Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635\u2013652","DOI":"10.1007\/s00401-009-0523-2"},{"key":"5243_CR4","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ (2006) Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281:29739\u201329752","journal-title":"J Biol Chem"},{"key":"5243_CR5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2990.2008.00937.x","volume":"34","author":"J Attems","year":"2008","unstructured":"Attems J, Jellinger KA (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease. Neuropathol Appl Neurobiol 34:466\u2013467","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5243_CR6","doi-asserted-by":"crossref","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL III, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","DOI":"10.1007\/s00401-009-0538-8"},{"key":"5243_CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"5243_CR8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","volume":"32","author":"A Bloch","year":"2006","unstructured":"Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) \u03b1-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32:284\u2013295","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5243_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"5243_CR10","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404\u20131410","journal-title":"Neurology"},{"key":"5243_CR11","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/mds.21065","volume":"21","author":"H Braak","year":"2006","unstructured":"Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered. Mov Disord 21:2042\u20132051","journal-title":"Mov Disord"},{"key":"5243_CR12","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K (2008) Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925","journal-title":"Neurology"},{"key":"5243_CR13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/mds.22484","volume":"24","author":"A Bruck","year":"2009","unstructured":"Bruck A, Aalto S, Rauhala E, Bergman J, Marttila R, Rinne JO (2009) A follow-up study on 6-[18F]fluoro-l-dopa uptake in early Parkinson\u2019s disease shows nonlinear progression in the putamen. Mov Disord 24:1009\u20131015","journal-title":"Mov Disord"},{"key":"5243_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn2477","volume":"9","author":"P Brundin","year":"2008","unstructured":"Brundin P, Li JY, Holton JL, Lindvall O, Revesz T (2008) Research in motion: the enigma of Parkinson\u2019s disease pathology spread. Nat Rev Neurosci 9:741\u2013745","journal-title":"Nat Rev Neurosci"},{"key":"5243_CR15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","volume":"64","author":"RE Burke","year":"2008","unstructured":"Burke RE, Dauer WT, Vonsattel JPG (2008) The Braak staging scheme for Parkinson\u2019s disease: a reappraisal. Ann Neurol 64:485\u2013491","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"5243_CR16","first-page":"S22","volume":"23","author":"SA Burns","year":"2008","unstructured":"Burns SA, Moran CR, Pingerelli PL, Ozols VV, Burns RS (2008) Redefining the Lewy body: evidence of distinct protein composition and nonrandom assembly process (abstr). Mov Disord 23(Suppl 1):S22","journal-title":"Mov Disord"},{"key":"5243_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/brain\/awn340","volume":"132","author":"P Calabresi","year":"2009","unstructured":"Calabresi P, Mercuri NB, Di Filippo M (2009) Synaptic plasticity, dopamine and Parkinson\u2019s disease: one step ahead. Brain 132:285\u2013287","journal-title":"Brain"},{"key":"5243_CR18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/NEN.0b013e318177eaf4","volume":"67","author":"RJ Castellani","year":"2008","unstructured":"Castellani RJ, Lee HG, Zhu X, Perry G, Smith MA (2008) Alzheimer disease pathology as a host response. J Neuropathol Exp Neurol 67:523\u2013531","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","volume":"74","author":"C Colosimo","year":"2003","unstructured":"Colosimo C, Hughes AJ, Kilford L, Lees AJ (2003) Lewy body cortical involvement may not always predict dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 74:852\u2013856","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5243_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-6606-2-5","volume":"2","author":"V Cullen","year":"2009","unstructured":"Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, Boston H, Saftig P, Woulfe J, Feany MB, Myllykangas L, Schlossmacher MG, Tyynela J (2009) Cathepsin D expression level affects \u03b1-synuclein processing, aggregation, and toxicity in vivo. Mol Brain 2:5","journal-title":"Mol Brain"},{"key":"5243_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF00310030","volume":"83","author":"GE Dale","year":"1992","unstructured":"Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN (1992) Relationships between Lewy bodies and pale bodies in Parkinson\u2019s disease. Acta Neuropathol 83:525\u2013529","journal-title":"Acta Neuropathol"},{"key":"5243_CR22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","volume":"65","author":"A DelleDonne","year":"2008","unstructured":"DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW (2008) Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 65:1074\u20131080","journal-title":"Arch Neurol"},{"key":"5243_CR23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","volume":"115","author":"DW Dickson","year":"2008","unstructured":"Dickson DW, Fujishiro H, Delledonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease. Acta Neuropathol 115:437\u2013444","journal-title":"Acta Neuropathol"},{"key":"5243_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-002-0563-3","volume":"104","author":"JE Duda","year":"2002","unstructured":"Duda JE, Giasson BI, Mabon ME, Miller DC, Golbe LI, Lee VM, Trojanowski JQ (2002) Concurrence of \u03b1-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol 104:7\u201311","journal-title":"Acta Neuropathol"},{"key":"5243_CR25","first-page":"545","volume-title":"Neurodegenerative diseases","author":"JM Fearnley","year":"1994","unstructured":"Fearnley JM, Lees AJ (1994) Pathology of Parkinson\u2019s disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 545\u2013554"},{"key":"5243_CR26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1532-5415.1969.tb01316.x","volume":"17","author":"LS Forno","year":"1969","unstructured":"Forno LS (1969) Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism. J Am Geriatr Soc 17:557\u2013575","journal-title":"J Am Geriatr Soc"},{"key":"5243_CR27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1750-3639.2008.00169.x","volume":"18","author":"K Fujimi","year":"2008","unstructured":"Fujimi K, Sasaki K, Noda K, Wakisaka Y, Tanizaki Y, Matsui Y, Sekita A, Iida M, Kiyohara Y, Kanba S, Iwaki T (2008) Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study. Brain Pathol 18:317\u2013325","journal-title":"Brain Pathol"},{"issue":"Suppl.1","key":"5243_CR28","first-page":"S30","volume":"23","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Ahn TB, Frigerio R, Uchikado H, Klos KJ, Josephs KA, DelleDonne A, Parisi JE, Ahlskog JE, Dickson DW (2008) Incidental Lewy bodies in various neurodegenerative disorders (abstr.). Mov Disord 23(Suppl.1):S30","journal-title":"Mov Disord"},{"key":"5243_CR29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/NEN.0b013e31817d7a1d","volume":"67","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW (2008) Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 67:649\u2013656","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00401-008-0398-7","volume":"116","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Tsuboi Y, Lin WL, Uchikado H, Dickson DW (2008) Co-localization of tau and \u03b1-synuclein in the olfactory bulb in Alzheimer\u2019s disease with amygdala Lewy bodies. Acta Neuropathol 116:269\u2013275","journal-title":"Acta Neuropathol"},{"key":"5243_CR31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.20819","volume":"59","author":"WR Galpern","year":"2006","unstructured":"Galpern WR, Lang AE (2006) Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 59:449\u2013458","journal-title":"Ann Neurol"},{"key":"5243_CR32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","volume":"58","author":"JE Galvin","year":"2001","unstructured":"Galvin JE, Lee VM, Trojanowski JQ (2001) Synucleinopathies: clinical and pathological implications. Arch Neurol 58:186\u2013190","journal-title":"Arch Neurol"},{"key":"5243_CR33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archneur.63.4.584","volume":"63","author":"S Greffard","year":"2006","unstructured":"Greffard S, Verny M, Bonnet AM, Beinis JY, Gallinari C, Meaume S, Piette F, Hauw JJ, Duyckaerts C (2006) Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 63:584\u2013588","journal-title":"Arch Neurol"},{"key":"5243_CR34","unstructured":"Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C (2008) A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging (online May 3, 2008)"},{"key":"5243_CR35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol 115:409\u2013415","journal-title":"Acta Neuropathol"},{"key":"5243_CR36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0967-5868(96)90083-1","volume":"3","author":"GM Halliday","year":"1996","unstructured":"Halliday GM, McRitchie DA, Cartwright H, Pamphlett R, Hely MA, Morris JGL (1996) Midbrain neuropathology in idiopathic Parkinson\u2019s disease and diffuse Lewy body disease. J Clin Neurosci 3:52\u201360","journal-title":"J Clin Neurosci"},{"key":"5243_CR37","first-page":"99","volume":"70","author":"GM Halliday","year":"2006","unstructured":"Halliday GM, Del Tredici K, Braak H (2006) Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson\u2019s disease. J Neural Transm Suppl 70:99\u2013103","journal-title":"J Neural Transm Suppl"},{"key":"5243_CR38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using \u03b1-synuclein immunohistochemistry. Brain Pathol 10:378\u2013384","journal-title":"Brain Pathol"},{"key":"5243_CR39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355\u2013363","journal-title":"Acta Neuropathol"},{"key":"5243_CR40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20\u00a0years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"key":"5243_CR41","first-page":"889","volume-title":"Greenfield\u2019s neuropathology","author":"PG Ince","year":"2008","unstructured":"Ince PG, Clark B, Holton J, Revesz T, Wharton SB (2008) Disorders of movement and system degenerations. In: Love S, Louis DN, Ellison DW (eds) Greenfield\u2019s neuropathology, 8th edn. Hodder Arnold, London, pp 889\u20131030","edition":"8"},{"key":"5243_CR42","first-page":"A58","volume":"26","author":"M Ishiyama","year":"2006","unstructured":"Ishiyama M, Yagishita S, Hasegawa K, Yokoyama T (2006) Ultrastructural study (tEM and sEM) of cortical Lewy bodies. Neuropathol 26:A58","journal-title":"Neuropathol"},{"key":"5243_CR43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","volume":"62","author":"T Ishizawa","year":"2003","unstructured":"Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW (2003) Colocalization of tau and \u03b1-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 62:389\u2013397","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR44","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","volume":"111","author":"KA Jellinger","year":"2004","unstructured":"Jellinger KA (2004) Lewy body-related \u03b1-synucleinopathy in the aged human brain. J Neural Transm 111:1219\u20131235","journal-title":"J Neural Transm"},{"key":"5243_CR45","first-page":"267","volume-title":"Degenerative diseases of the nervous system","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA (2007) Lewy body disorders. In: Youdim MBH, Riederer P, Mandel SA, Battistin L, Lajtha A (eds) Degenerative diseases of the nervous system. Springer Science, New York, pp 267\u2013343"},{"key":"5243_CR46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-211-73574-9_12","volume":"72","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA (2007) Morphological substrates of Parkinsonism with and without dementia. A retrospective clinico-pathological study. J Neural Transm Suppl 72:91\u2013104","journal-title":"J Neural Transm Suppl"},{"key":"5243_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","volume":"116","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116:1\u201316","journal-title":"Acta Neuropathol"},{"key":"5243_CR48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","volume":"1792","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009) A critical evaluation of current staging of \u03b1-synuclein pathology in Lewy body disorder. Biochim Biophys Acta 1792:730\u2013740","journal-title":"Biochim Biophys Acta"},{"key":"5243_CR49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-008-0381-3","volume":"116","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008) Controversies over the staging of \u03b1-synuclein pathology in Parkinson\u2019s disease. Acta Neuropathol 116:125\u2013128","journal-title":"Acta Neuropathol"},{"issue":"Suppl.1","key":"5243_CR50","first-page":"S247","volume":"23","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis ME, Roncaroli F, Pearce RK, Gentleman S (2008) Non-stereotypical distribution of \u03b1-synuclein in the spinal cord and brain of a patient with dementia with Lewy bodies (DLB) (abstr.). Mov Disord 23(Suppl.1):S247","journal-title":"Mov Disord"},{"key":"5243_CR51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1750-3639.2008.00140.x","volume":"18","author":"T Kanazawa","year":"2008","unstructured":"Kanazawa T, Uchihara TAT, Nakamura A, Orimo S, Mizusawa H (2008) Three-layered structure shared between Lewy bodies and Lewy neurites\u2014three-dimensional reconstruction of triple-labeled sections. Brain Pathol 18:415\u2013422","journal-title":"Brain Pathol"},{"key":"5243_CR52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-510X(03)00037-6","volume":"211","author":"O Katsuse","year":"2003","unstructured":"Katsuse O, Iseki E, Marui W, Kosaka K (2003) Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci 211:29\u201335","journal-title":"J Neurol Sci"},{"key":"5243_CR53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14:504\u2013506","journal-title":"Nat Med"},{"key":"5243_CR54","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/mds.22207","volume":"23","author":"GG Kovacs","year":"2008","unstructured":"Kovacs GG, Milenkovic IJ, Preusser M, Budka H (2008) Nigral burden of \u03b1-synuclein correlates with striatal dopamine deficit. Mov Disord 23:1608\u20131612","journal-title":"Mov Disord"},{"key":"5243_CR55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0705-2","volume":"106","author":"E Kovari","year":"2003","unstructured":"Kovari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson\u2019s disease. Acta Neuropathol 106:83\u201388","journal-title":"Acta Neuropathol"},{"key":"5243_CR56","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","volume":"62","author":"E Kuusisto","year":"2003","unstructured":"Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of \u03b1-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241\u20131253","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2006.04.024","volume":"200","author":"HG Lee","year":"2006","unstructured":"Lee HG, Zhu X, Takeda A, Perry G, Smith MA (2006) Emerging evidence for the neuroprotective role of \u03b1-synuclein. Exp Neurol 200:1\u20137","journal-title":"Exp Neurol"},{"key":"5243_CR58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tins.2004.01.007","volume":"27","author":"VM Lee","year":"2004","unstructured":"Lee VM, Giasson BI, Trojanowski JQ (2004) More than just two peas in a pod: common amyloidogenic properties of tau and \u03b1-synuclein in neurodegenerative diseases. Trends Neurosci 27:129\u2013134","journal-title":"Trends Neurosci"},{"key":"5243_CR59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1750-3639.2007.00048.x","volume":"17","author":"JB Leverenz","year":"2007","unstructured":"Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J, Pan C, Shin J, Zhu D, Zhang J (2007) Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol 17:139\u2013145","journal-title":"Brain Pathol"},{"key":"5243_CR60","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1750-3639.2007.00117.x","volume":"18","author":"JB Leverenz","year":"2008","unstructured":"Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18:220\u2013224","journal-title":"Brain Pathol"},{"key":"5243_CR61","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P (2008) Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med 14:501\u2013503","journal-title":"Nat Med"},{"issue":"suppl 1","key":"5243_CR62","first-page":"S39","volume":"24","author":"V Licker","year":"2009","unstructured":"Licker V, Dayon L, Turck N, C\u00f4te M, Rodrigo N, Hochstrasser DF, Sanchez JC, Burkhard PR (2009) Proteomic analysis of the substantia nigra in patients with Parkinson\u2019s disease (abstr.). Mov Disord 24(suppl 1):S39","journal-title":"Mov Disord"},{"key":"5243_CR63","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/nen.0b013e3180415e42","volume":"66","author":"I Litvan","year":"2007","unstructured":"Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, Langston WJ, Di Monte DA, Gasser T, Hagg T, Hardy J, Jenner P, Melamed E, Myers RH, Parker D Jr, Price DL (2007) The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol 66:251\u2013257","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR64","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00702-008-0027-6","volume":"115","author":"N MacInnes","year":"2008","unstructured":"MacInnes N, Iravani MM, Perry E, Piggott M, Perry R, Jenner P, Ballard C (2008) Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems. J Neural Transm 115:869\u2013878","journal-title":"J Neural Transm"},{"key":"5243_CR65","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/NEN.0b013e3181ac10a7","volume":"68","author":"WR Markesbery","year":"2009","unstructured":"Markesbery WR, Jicha GA, Liu H, Schmitt FA (2009) Lewy body pathology in normal elderly subjects. J Neuropathol Exp Neurol 68:816\u2013822","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR66","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/01.wnl.0000312515.52545.51","volume":"70","author":"C Marras","year":"2008","unstructured":"Marras C, Lang A (2008) Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain. Neurology 70:1996\u20132003","journal-title":"Neurology"},{"key":"5243_CR67","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s004019900168","volume":"100","author":"PM Mattila","year":"2000","unstructured":"Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M (2000) \u03b1-Synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease. Acta Neuropathol 100:285\u2013290","journal-title":"Acta Neuropathol"},{"key":"5243_CR68","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"5243_CR69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-008-0350-x","volume":"115","author":"GE Meredith","year":"2008","unstructured":"Meredith GE, Sonsalla PK, Chesselet MF (2008) Animal models of Parkinson\u2019s disease progression. Acta Neuropathol 115:385\u2013398","journal-title":"Acta Neuropathol"},{"key":"5243_CR70","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"5243_CR71","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.jnen.0000171652.40083.15","volume":"64","author":"CM M\u00fcller","year":"2005","unstructured":"M\u00fcller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M, Braak H (2005) Staging of sporadic Parkinson disease-related \u03b1-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol 64:623\u2013628","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR72","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuroscience.2008.01.030","volume":"152","author":"G Muntane","year":"2008","unstructured":"Muntane G, Dalfo E, Martinez A, Ferrer I (2008) Phosphorylation of tau and \u03b1-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer\u2019s disease, and in Parkinson\u2019s disease and related \u03b1-synucleinopathies. Neuroscience 152:913\u2013923","journal-title":"Neuroscience"},{"key":"5243_CR73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.expneurol.2007.11.019","volume":"210","author":"K Obi","year":"2008","unstructured":"Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T, Mizuno Y, Mochizuki H (2008) Relationship of phosphorylated \u03b1-synuclein and tau accumulation to A\u03b2 deposition in the cerebral cortex of dementia with Lewy bodies. Exp Neurol 210:409\u2013420","journal-title":"Exp Neurol"},{"key":"5243_CR74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-012088592-3\/50012-8","volume-title":"Neurobiology of disease","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, McLean PJ, Hyman BT (2007) Protein aggregation disorders. In: Gilman S (ed) Neurobiology of disease. Elsevier, Academic Press, Amsterdam, pp 111\u2013123"},{"key":"5243_CR75","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","volume":"132","author":"KE Paleologou","year":"2009","unstructured":"Paleologou KE, Kragh CL, Mann DM, Salem SA, Al-Shami R, Allsop D, Hassan AH, Jensen PH, El-Agnaf OM (2009) Detection of elevated levels of soluble \u03b1-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132:1093\u20131101","journal-title":"Brain"},{"key":"5243_CR76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnen\/62.4.363","volume":"62","author":"L Parkkinen","year":"2003","unstructured":"Parkkinen L, Soininen H, Alafuzoff I (2003) Regional distribution of \u03b1-synuclein pathology in unimpaired aging and Alzheimer disease. J Neuropathol Exp Neurol 62:363\u2013367","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR77","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1789.2005.00644.x","volume":"25","author":"L Parkkinen","year":"2005","unstructured":"Parkkinen L, Pirttila T, Tervahauta M, Alafuzoff I (2005) Widespread and abundant \u03b1-synuclein pathology in a neurologically unimpaired subject. Neuropathology 25:304\u2013314","journal-title":"Neuropathology"},{"key":"5243_CR78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","volume":"115","author":"L Parkkinen","year":"2008","unstructured":"Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging\/categorization of \u03b1-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399\u2013407","journal-title":"Acta Neuropathol"},{"key":"5243_CR79","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.21446","volume":"64","author":"T Peuralinna","year":"2008","unstructured":"Peuralinna T, Oinas M, Polvikoski T, Paetau A, Sulkava R, Niinisto L, Kalimo H, Hernandez D, Hardy J, Singleton A, Tienari PJ, Myllykangas L (2008) Neurofibrillary tau pathology modulated by genetic variation of \u03b1-synuclein. Ann Neurol 64:348\u2013352","journal-title":"Ann Neurol"},{"key":"5243_CR80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-008-0438-3","volume":"117","author":"JH Power","year":"2009","unstructured":"Power JH, Blumbergs PC (2009) Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol 117:63\u201373","journal-title":"Acta Neuropathol"},{"issue":"Suppl","key":"5243_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2008.02057.x","volume":"15","author":"A Probst","year":"2008","unstructured":"Probst A, Bloch A, Tolnay M (2008) New insights into the pathology of Parkinson\u2019s disease: does the peripheral autonomic system become central? Eur J Neurol 15(Suppl):1\u20134","journal-title":"Eur J Neurol"},{"key":"5243_CR82","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.parkreldis.2007.06.015","volume":"13","author":"P Riederer","year":"2007","unstructured":"Riederer P, Gerlach M, Muller T, Reichmann H (2007) Relating mode of action to clinical practice: dopaminergic agents in Parkinson\u2019s disease. Parkinsonism Relat Disord 13:466\u2013479","journal-title":"Parkinsonism Relat Disord"},{"key":"5243_CR83","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnen\/63.7.742","volume":"63","author":"Y Saito","year":"2004","unstructured":"Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, Yamanouchi H, Murayama S (2004) Lewy body-related \u03b1-synucleinopathy in aging. J Neuropathol Exp Neurol 63:742\u2013749","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR84","first-page":"184","volume-title":"The Dementias 2. Blue books of neurology","author":"MG Schlossmacher","year":"2007","unstructured":"Schlossmacher MG (2007) \u03b1-Synuclein and synucleinopathies. In: Growdon JH, Rossor MN (eds) The Dementias 2. Blue books of neurology. Butterworth-Heinemann, Oxford, pp 184\u2013213"},{"key":"5243_CR85","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/mds.22306","volume":"24","author":"L Shehadeh","year":"2009","unstructured":"Shehadeh L, Mitsi G, Adi N, Bishopric N, Papapetropoulos S (2009) Expression of Lewy body protein septin 4 in postmortem brain of Parkinson\u2019s disease and control subjects. Mov Disord 24:204\u2013210","journal-title":"Mov Disord"},{"key":"5243_CR86","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.21204","volume":"62","author":"V Sossi","year":"2007","unstructured":"Sossi V, de la Fuente-Fernandez R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ (2007) Dopamine transporter relation to dopamine turnover in Parkinson\u2019s disease: a positron emission tomography study. Ann Neurol 62:468\u2013474","journal-title":"Ann Neurol"},{"key":"5243_CR87","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1074\/jbc.M802223200","volume":"283","author":"N Sugeno","year":"2008","unstructured":"Sugeno N, Takeda A, Hasegawa T, Kobayashi M, Kikuchi A, Mori F, Wakabayashi K, Itoyama Y (2008) Serine 129 phosphorylation of \u03b1-synuclein induces unfolded protein response-mediated cell death. J Biol Chem 283:23179\u201323188","journal-title":"J Biol Chem"},{"key":"5243_CR88","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1074\/jbc.M310994200","volume":"279","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T, Mouradian MM (2004) Aggresomes formed by \u03b1-synuclein and synphilin-1 are cytoprotective. J Biol Chem 279:4625\u20134631","journal-title":"J Biol Chem"},{"issue":"Suppl 12","key":"5243_CR89","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1002\/mds.20538","volume":"20","author":"GK Tofaris","year":"2005","unstructured":"Tofaris GK, Spillantini MG (2005) \u03b1-Synuclein dysfunction in Lewy body diseases. Mov Disord 20(Suppl 12):S37\u2013S44","journal-title":"Mov Disord"},{"key":"5243_CR90","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","volume":"65","author":"H Uchikado","year":"2006","unstructured":"Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of \u03b1-synucleinopathy. J Neuropathol Exp Neurol 65:685\u2013697","journal-title":"J Neuropathol Exp Neurol"},{"key":"5243_CR91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","volume":"103","author":"VN Uversky","year":"2007","unstructured":"Uversky VN (2007) Neuropathology, biochemistry, and biophysics of \u03b1-synuclein aggregation. J Neurochem 103:17\u201337","journal-title":"J Neurochem"},{"key":"5243_CR92","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","volume":"42","author":"MJ Volles","year":"2003","unstructured":"Volles MJ, Lansbury PT Jr (2003) Zeroing in on the pathogenic form of \u03b1-synuclein and its mechanism of neurotoxicity in Parkinson\u2019s disease. Biochemistry 42:7871\u20137878","journal-title":"Biochemistry"},{"issue":"Suppl","key":"5243_CR93","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.parkreldis.2006.05.028","volume":"12","author":"K Wakabayashi","year":"2006","unstructured":"Wakabayashi K, Mori F, Takahashi H (2006) Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson\u2019s disease. Parkinsonism Relat Disord 12(Suppl):S92\u2013S98","journal-title":"Parkinsonism Relat Disord"},{"key":"5243_CR94","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00401-003-0750-x","volume":"106","author":"Y Wakisaka","year":"2003","unstructured":"Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T (2003) Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 106:374\u2013382","journal-title":"Acta Neuropathol"},{"key":"5243_CR95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-008-0375-1","volume":"116","author":"EA Waxman","year":"2008","unstructured":"Waxman EA, Duda JE, Giasson BI (2008) Characterization of antibodies that selectively detect \u03b1-synuclein in pathological inclusions. Acta Neuropathol 116:37\u201346","journal-title":"Acta Neuropathol"},{"key":"5243_CR96","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1212\/01.wnl.0000266626.64913.0f","volume":"69","author":"D Weisman","year":"2007","unstructured":"Weisman D, Cho M, Taylor C, Adame A, Thal LJ, Hansen LA (2007) In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology 69:356\u2013359","journal-title":"Neurology"},{"key":"5243_CR97","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-211-45295-0_47","volume":"70","author":"E Wolters","year":"2006","unstructured":"Wolters E, Braak H (2006) Parkinson\u2019s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309\u2013319","journal-title":"J Neural Transm Suppl"},{"key":"5243_CR98","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","volume":"70","author":"J Zaccai","year":"2008","unstructured":"Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of \u03b1-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042\u20131048","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5243-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-009-5243-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5243-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T02:33:59Z","timestamp":1710556439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-009-5243-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":98,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["5243"],"URL":"https:\/\/doi.org\/10.1007\/s00415-009-5243-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}